Communiqués Cencora, Inc.

Actions

COR

US03073E1055

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE 22:00:02 17/07/2026 Varia. 5j. Varia. 1 janv.
307,90 USD -0,03% Graphique intraday de Cencora, Inc. +1,47% -8,84%

Communiqués

14/07 Cencora : World Courier Expands Cold Chain Capabilities | Cencora PU
01/07 Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release BU
15/06 Cencora Announces Samantha Hammock as Chief Human Resources Officer BU
27/05 Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer BU
21/05 Cencora Announces Updated Fiscal Year 2026 Financial Outlook BU
06/05 Cencora : Q2 2026 Cencora Earnings Presentation PU
06/05 Cencora: Fiscal Q2 Earnings Snapshot AQ
06/05 Cencora Reports Fiscal 2026 Second Quarter Results BU
24/04 Cencora : Pharmaceutical supply chain experts discuss the transition to the FDA’s new 12-digit NDC format with Drug Topics and Pharmaceutical Commerce PU
24/04 RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor AQ
01/04 Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release BU
25/03 The Next Phase Of Vertical Integration: Wholesalers Follow The PBM Playbook AQ
23/03 Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business BU
18/03 Cencora Releases Fiscal Year 2025 Corporate Responsibility Report, Marking 10 Years of Purpose in Action AQ
17/03 Cencora Announces Financial Leadership Transition BU
09/03 Cencora : CDP Climate Change Disclosure PU
06/03 Cencora : Human Rights Statement PU
18/02 Covetrus and MWI Animal Health to Merge BU
16/02 Cencora Closes $3.0 Billion Senior Notes Offering AQ
13/02 Cencora Closes $3.0 Billion Senior Notes Offering BU
10/02 Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 BU
09/02 Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors AQ
04/02 Cencora: Fiscal Q1 Earnings Snapshot AQ
04/02 Cencora : First Quarter 2026 Presentation PU
04/02 Cencora Reports Fiscal 2026 First Quarter Results BU
Aucun résultat pour cette recherche